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Individuals living in regions of intense malaria transmission exhibit natural immunity that allows them to
be without fever and other symptoms for most of the time despite frequent parasitization. Although this tol-
erance of parasitemia appears to be more effective in children than in adults (as evidenced by lower para-
sitemia fever thresholds with age), adults do exhibit a degree of tolerance but the mechanism(s) underlying this
are unclear. Asymptomatic malaria-exposed children have higher levels of nitric oxide (NO) than children with
severe disease, and NO has been proposed as a mediator of malarial tolerance. However, the ability of highly
malaria-exposed asymptomatic adults to generate high-level basal NO is unknown, as is the relationship be-
tween NO and malaria tolerance in adults. The relationship between NO and malaria parasitemia was there-
fore determined in asymptomatic adults from Papua, Indonesia. Adults with Plasmodium falciparum para-
sitemia had markedly increased basal systemic NO production relative to aparasitemic Papuan controls, who
in turn produced more NO than healthy controls from a region without malaria. Immunoglobulin E levels were
universally elevated in malaria-exposed Papuan subjects, suggesting that the prevalence of intestinal parasi-
tosis may be high and that nonmalarial infection may also contribute to high basal NO production. Basal
peripheral blood mononuclear cell (PBMC) NO synthase activity was elevated in Papuans but poorly corre-
lated with systemic NO production, suggesting that NO production in this setting arises not only from PBMCs but
also from other tissue and cellular sources. NO production was associated with and may contribute to malaria
tolerance in Papuan adults.
The natural history of malaria in regions where it is endemic
is characterized by long periods of asymptomatic parasitemia
punctuated by episodic clinical attacks that decrease in fre-
quency with age (40, 57). Although the immune processes
preventing symptoms such as fever in chronically parasitized
individuals are poorly understood, this aspect of immunity
(malarial tolerance) is thought to be most efficient in childhood
and then declines with age (18, 41, 70). This is because the
threshold of parasitemia associated with fever appears to be
age dependent and higher in children than adults from geo-
graphically diverse regions where malaria is endemic (56, 65).
Nitric oxide (NO) has been proposed as the mediator of tol-
erance in populations in regions where malaria is endemic (15)
on the basis that NO production in asymptomatic malaria-
exposed children exceeds that of children with severe malaria
(1, 5) and that parallels exist between the malaria tolerant state
and endotoxin tolerance (72). Indeed, in 1965 it was shown
that cross-tolerance to bacterial lipopolysaccharide could be
induced by experimentally infecting prisoners with Plasmo-
dium vivax (61); this finding is in accord with present molecular
models of tolerance (21). Downregulation of the endogenous
pyrogen tumor necrosis factor alpha (TNF-) and upregula-
tion of NO are thought to be typical manifestations of endo-
toxin tolerance in mononuclear cells (72). In addition, NO is
thought to play a key role in tolerance induction (23, 58, 77).
This latter role of NO is the basis on which the above hypoth-
esis was formulated (15).
Much less is known of NO production in asymptomatic ma-
laria-exposed adults than in children. The majority of studies
examining NO production in malaria-exposed adults have re-
ported NO metabolite levels in the setting of clinical disease (7,
22, 34, 46, 48, 54, 67, 69), reflecting altered NO production in
clinical malaria. Most of these studies did not control for di-
etary nitrate ingestion (7, 22, 34, 46, 48, 54) or altered nitrate
handling in renal impairment (4, 7, 34, 48, 54, 69). Very few
studies have reported NO metabolite levels in asymptomatic
malaria-exposed adults (7, 15, 48, 54), and none of these con-
trolled for the confounding effect of dietary nitrite-plus-nitrate
(NOx) ingestion. Some studies have hypothesized that malaria-
exposed adults are less tolerant of parasitemia than children
(15, 56) and that their systemic NO production would mirror
that of healthy non-malaria-exposed adults due to purported
hyporesponsiveness of peripheral blood mononuclear cells
(PBMCs) to nitric oxide synthase 2 (NOS2) induction (15).
However, adults from regions where malaria is highly endemic
rarely experience clinical illness and have long been reported
to tolerate parasitemias (sometimes exceeding 500 parasites/
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l) in the absence of symptoms (41, 52). These basic epidemi-
ological observations are consistent with the notion that toler-
ance in adults is less effective than in children (56) and also,
importantly, with the notion that these adults are nevertheless
more tolerant than would be expected of malaria-naive sub-
jects (26, 42).
Recent work has established that experimentally induced
Plasmodium falciparum infection strongly induces NOS in
PBMCs in malaria-naive adult human volunteers at low levels
of parasitemia that are detectable by PCR but not by micros-
copy (53). This finding agrees with in vitro studies (66) and a
previous in vivo study linking P. falciparum to NO production
in Tanzanian children, in which children with microscopically
proven asymptomatic P. falciparum parasitemia produced sig-
nificantly more NO than children negative for P. falciparum on
both microscopy and PCR (6). It is also possible that other sub-
clinical infections (such as intestinal parasitosis [46]) contrib-
ute to basal NO production in tropical regions via activation of
monocyte CD23 receptors (33) or other mechanisms (24, 64).
In the present study, we sought to explore the relationship
between NO production and tolerance in adults in malaria-
endemic areas. We hypothesized that basal NO production in
asymptomatic adults exposed to intense malaria transmission
would be higher than in healthy controls from a region of low
malaria endemicity, who in turn would produce more NO than
non-malaria-exposed controls. In asymptomatic adults exposed
to intense malaria transmission, we hypothesized that, as in
children, NO production and/or PBMC NOS activity would be
higher in adults with asymptomatic parasitemia than in those
without microscopically detectable parasitemia. Further, we
expected that PBMCs would be the predominant source of NO
production and therefore that the NOS activity of PBMCs
would correlate with measures of systemic NO production.
MATERIALS AND METHODS
Study sites. Subjects were recruited in March 1999 from 11 villages within
close proximity of Genyem township (Papua province, Indonesia), which is
located ca. 100 km by road from the provincial capital Jayapura and 20 km inland
from the northern coast. The climate of this heavily forested region is typically
tropical with a rainy season between November and May. Malaria transmission
is reported to be perennial in this region but more intense during the rainy
season, and all four malaria species parasitizing humans have been observed
(68). In a comprehensive malariometric survey performed between November
and December 1998, the prevalence of asexual parasitemia in children 10 years
in age was 39% (mesoendemic) and the spleen enlargement rate was 51% (hyper-
endemic [68]) These rates are inclusive of nonindigenous transmigrants (mostly
Javanese) and are thought to under-estimate the true rates in indigenous Pap-
uans due to less frequent use of bed nets and closer proximity to the forest in the
latter group (68). The clinical epidemiology of malaria in Genyem is character-
ized by a very low incidence of severe disease and clinically indistinguishable
uncomplicated attacks due to P. falciparum and P. vivax (68). Malarial ende-
micity in the urbanized city of Jayapura is difficult to estimate with certainty
but is estimated to be significantly lower than in Genyem (20a, 20b).
Enrollment of subjects and controls. Ethical approval to conduct the study was
obtained from the Joint Institutional Ethics Committee of the Royal Darwin
Hospital and Menzies School of Health Research of Australia and from the
Ethics Committee of the National Institute of Health Research and Develop-
ment, Indonesian Ministry of Health, Jakarta, Indonesia. Approval to conduct
the study was also sought and obtained from the relevant provincial, regional,
and local administrative and health authorities within Papua province. Permis-
sion to work in each village was obtained from the respective village leaders after
explanation of the study protocols and consent process. Written informed con-
sent was obtained from individual participants after explanation of the study
protocol in Bahasa Indonesia. All healthy adults aged 16 years and older living
within the study area were eligible to enter the study. Volunteers presenting for
screening underwent a clinical assessment questionnaire administered by the
study team, measurement of axillary body temperature by using a digital clinical
thermometer, and collection of thick and thin blood smear by fingerprick.
The clinical criteria for enrollment were as follows: no fever history or treat-
ment for malaria within the past week, no clinical evidence of malaria or other
infection, no diarrhea, and no current pregnancy. Screened subjects who fulfilled
these criteria were provisionally allocated into one of three study groups on the
basis of screening microscopy: (i) asymptomatic P. falciparum infection, (ii)
asymptomatic P. vivax infection, and (iii) microscopically aparasitemic healthy
controls. Potential enrollees were then selected from those eligible with the aim
of including balanced numbers of parasitemic and aparasitemic individuals and
approximately equal sex and age distributions in each group. Enrollees were
supervised overnight at the local health center, where clinical details were re-
checked at interview in the evening and measurement of axillary temperature
was repeated. A third axillary temperature was recorded the following morning.
Urban Papuan adult controls were recruited in Jayapura between July 1999 and
July 2000, and urban adult non-malaria-exposed Australian Research Institute
employee controls were recruited in Darwin in February 2002 with similar cri-
teria and methodology as for the subjects. Axillary temperatures were measured
once in Jayapura controls and twice in Darwin controls, 16 h apart.
Sample collection. To control for the confounding effect of dietary nitrate
ingestion on NOx levels (27), subjects and controls were fasted for a minimum of
12 h overnight after a low nitrate meal of chicken and rice (2). Chicken from the
three study sites was confirmed to be preservative- and additive-free through
discussion directly with the suppliers and was cooked and then consumed without
additives or condiments. Liberal quantities of locally sourced nitrate-free water
were permitted during this period, but smoking and chewing of betel nut were
prohibited. Adherence to the fasting protocol was confirmed by direct supervi-
sion of subjects and by using a questionnaire for controls. First-void urines were
discarded after the fast, after which urine and venous blood was collected. Urine
from subjects was examined by dipstick (Bayer Diagnostics) to detect urinary
tract infection and then stored on isopropanol (20% of final volume) to prevent
bacterial overgrowth. Whole blood was processed within hours, from which
plasma was removed and PBMCs separated by density centrifugation and then
cryopreserved at 70°C until assay.
Laboratory assays. Two thick and thin blood smears from consecutive days
were taken to account for periodic fluctuation of parasite densities (10, 20).
Smears were stained with 4% Giemsa solution and examined by a microscopist
(S.S.) with more than 20 years of experience. Negative smears were those with no
parasites seen on examination of 100 high-powered (1,000 magnification)
fields. Total leukocyte counts in EDTA-anticoagulated blood from Genyem (for
calculation of parasitemias) were measured by using an automated Coulter
counter. Systemic NO production was determined by measuring the concentra-
tion of NOx in urine and plasma with Aspergillus nitrate reductase coupled with
the Griess reaction (3). Urine and plasma concentrations of creatinine (Cr) were
measured on an automated analyzer. Plasma immunoglobulin E (IgE) levels
were measured by sandwich enzyme-linked immunosorbent assay using affinity-
purified goat antibody to human IgE as the antigen (Kirkegaard & Perry Lab-
oratories [KPL], Gaithersburg, Md.) and peroxidase-labeled affinity-purified
goat antibody to human IgE as the secondary antibody (KPL). Reactions were
developed with 3,3,5,5-tetramethylbenzidine substrate (KPL), stopped by the
addition of 0.5 N sulfuric acid, read at 450 nm (reference 650 nm), and then
quantitated against a standard curve. Urine NOx excretion was routinely ex-
pressed as a ratio of NOx/Cr to control for differences in urine concentration
between subjects. Fractional excretion of NOx (FENOx), the percentage of NOx
that is excreted, was calculated by the formula: FENOx  100  (urine/plasma
TABLE 1. Baseline characteristics of study subjects and controls
Subject
group No.
Median age
(yr)a (IQR)
%
Maleb
No. of subjects
(median parasitemia/
l) infected with:
P. falciparum P. vivax Bothc
Genyem 40 24.5 (19–33.5) 58 12 (311) 5 (67.5) 1 (148/37)
Jayapura 43 24 (18–30) 47 0 0 0
Darwin 22 33 (26–42) 41 0 0 0
a The difference among ages (P  0.001) was assessed with the Kruskal-Wallis
test.
b P  0.423 (Fisher exact test).
c One subject was infected with both P. falciparum and P. vivax, with para-
sitemia of each in parentheses, respectively.
VOL. 71, 2003 NITRIC OXIDE AND MALARIA IN PAPUAN ADULTS 3683
 o
n
 N
ovem
ber 10, 2013 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
NOx)/(urine/plasma Cr). NOS activity was measured in PBMC pellet lysates by
measuring the amount of [14C]arginine that was converted to citrulline per mg of
total cellular protein per h (71). PBMC lysates were analyzed for NOS2 antigen
content by immunoblot, as previously described (62). An immunoblot was con-
sidered positive if a clear band was visible at 130 to 131 kDa.
Statistical methods. All statistical analyses were performed by using Stata 7.0
software (StataCorp.). In general, summary statistics are presented as means
with standard deviations for normally distributed data and as medians with
interquartile ranges (IQR) for nonparametric data. The significance of binomial
probabilities was assessed by using an exact method (Stata Bitest). Pairwise
comparisons of nonparametric continuous data were performed by using the
Mann-Whitney U test. Correlation between continuous measures was checked
by using Spearman rank test. In all statistical tests, P values of 0.05 were
considered to indicate statistical significance.
RESULTS
Baseline characteristics of subjects. There were 179 volun-
teers from Genyem screened for entry into the study, from
which 56 subjects were enrolled. A total of 16 subjects met the
exclusion criteria subsequent to their initial screening: 3 had a
measured axillary temperature of 37.5°C, 9 gave a history of
fever, 12 gave a history of other symptoms consistent with
malaria, and 4 reported recent ingestion of antimalarial med-
ication. One other subject had a urinary tract infection and was
excluded from analyses involving urine results. There was no
significant difference in the age of men or women in the 40
included subjects whose baseline characteristics are shown in
Table 1. One subject was from Sulawesi and had been living in
Genyem for 2 years, and the remainder were coastal Melane-
sians. The mean duration of residence in Genyem was 20 years
(standard deviation of 10 years), with 25 of the subjects having
never lived elsewhere. All subjects were supervised overnight
at the Genyem Health Center, and no breaches to the fasting
protocol were observed. Two thick and thin smears were avail-
able for examination by the experienced microscopist in 34 of
the 40 subjects, and one smear only was available from 6 (all
aparasitemic). The parasitemias of the included group were
broadly representative of the screened group.
Baseline characteristics of controls. Of the 43 controls re-
cruited from Jayapura (Table 1), 14 (33%) were coastal
Melanesians, 6 (14%) were Melanesians from the highlands,
and the remainder had emigrated from other parts of Indone-
sia. Male Jayapura controls (median age, 28 years; IQR, 22 to
32) were significantly older than female controls (median age,
18 years; IQR, 16 to 25; P  0.002). Indonesian immigrants
(median age, 30 years; IQR, 24 to 33) were significantly older
than both coastal Melanesians (median age, 19 years; IQR, 16
to 22; P  0.001) and Melanesian highlanders (median age,
FIG. 1. Systemic and PBMC production of NO in the three study
groups. (A) Urine NOx excretion. Shown are the natural logarithms of
the ratio of urine NOx to Cr. The significance levels of pairwise com-
parisons are as follows: Genyem versus Jayapura, P  0.006; Genyem
versus Darwin, P  0.001; and Jayapura versus Darwin, P  0.02. (B)
Natural logarithms of NOx in plasma (in micromoles/liter). The sig-
nificance levels of pairwise comparisons are as follows: Genyem versus
Jayapura, P  0.008; Genyem versus Darwin, P  0.001; and Jayapura
versus Darwin, P  0.001. (C) Natural logarithms of PBMC NOS
activity (in picomoles of [14C]arginine converted to citrulline per mil-
ligram of total cellular protein/hour). The significance levels of pair-
wise comparisons are as follows: Genyem versus Jayapura, P  0.17;
Genyem versus Darwin, P  0.001; and Jayapura versus Darwin, P 
0.001. In each figure, the horizontal line represents the median and the
box extends from the 25th to the 75th percentiles. Vertical lines extend
no further than the most distant datum point or 1.5 times the IQR.
Outlying values are represented as small diamonds.
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17.5 years; IQR, 16 to 24; P 0.009). All of these controls were
confirmed on microscopy to be free of malaria parasitemia
upon initial screening in Jayapura and upon subsequent cross-
checking by the experienced microscopist (S.S.). Twenty-two
adult Darwin controls were enrolled, who were slightly older
than the Genyem subjects and Jayapura controls (Table 1), but
there was no significant difference in mean age between Dar-
win men and women. No controls admitted to breaching the
fasting protocol, and none had evidence of urinary tract infec-
tion on dipstick testing or microscopic examination of urine.
NO production and PBMC NOS activity or expression in
subjects and controls. Urine NOx/Cr and plasma NOx were
significantly correlated in all study groups: in the Genyem
subjects, Spearman rho [	]  0.72 (P  0.001); in the Jayapura
controls, 	  0.4 (P  0.008); and in the Darwin controls, 	 
0.51 (P  0.016). Both urine NOx/Cr and plasma NOx were
significantly higher in Genyem subjects than in the Jayapura
controls or Darwin controls and were also higher in Jayapura
controls than in Darwin controls (Fig. 1A and B). Levels of Cr
in plasma were within the normal range for all controls and for
all but 1 subject from Genyem, whose Cr was 140 mol/liter.
The results of all pairwise comparisons remained significant
when this subject was excluded from the statistical analyses.
Furthermore, the significance of each pairwise comparison was
maintained if the ratio of NOx/Cr in plasma was used in place
of plasma NOx in the statistical analysis (data not shown). As
a marker of renal tubular NOx handling, the median FENOx
levels in the Genyem subjects and Jayapura and Darwin con-
trols were 30, 27, and 33%, respectively. Neither urine NOx/Cr
nor plasma NOx were significantly correlated with age in any of
the groups.
Urine NOx/Cr did not vary with sex in any of the groups (nor
with ethnicity in Jayapura controls). However, plasma NOx
was significantly higher in male Jayapura controls (median, 31
mol/liter; IQR, 23 to 40 mol/liter) than in females (median,
12 mol/liter; IQR, 10 to 18 mol/liter; P  0.001). In that
group, plasma NOx was also significantly higher in coastal
Melanesians and controls from elsewhere in Indonesia than in
six Melanesian highlanders (five of whom were women). After
the NOx level in plasma was transformed to normality, the
significance of sex was retained in a multiple linear regression
model but that of ethnicity was not (nor was the effect of age
significant). PBMC NOS activity was higher in Genyem sub-
jects than in Jayapura controls, but this difference was not
significant (Fig. 1C). NOS activity was significantly lower in
Darwin controls than in both Genyem subjects and Jayapura
controls (Fig. 1C). NOS activity was not significantly correlated
with plasma NOx or urine NOx/Cr in any of the three study
locations, nor was it significantly related to age or sex (or eth-
nicity in Jayapura controls). Sufficient PBMC lysate for mea-
surement of NOS2 antigen content was available for 33 of the
40 Genyem subjects and for 33 of the 43 Jayapura controls.
NOS2 antigen was detected in all but one of the Genyem
subjects and in all 33 of the Jayapura controls. Figure 2 shows
a representative immunoblot, with a clear band visible at 130 to
131 kDa.
Effect of parasitemia in Genyem subjects on NO production
and PBMC NOS activity. Plasma NOx was significantly higher
in those with malaria parasitemia (median, 40 mol/liter; IQR,
16 to 36) than in those without it (median level of NOx in
plasma, 20 mol/liter; IQR, 16 to 36; P 0.020). Excluding the
one subject with mixed infection, plasma NOx was highest in
individuals with P. falciparum, intermediate in those with P.
vivax, and lowest in aparasitemic subjects (Fig. 3A). The dif-
ference in plasma NOx between P. falciparum parasitemic sub-
jects and aparasitemic subjects was significant, but those with
P. vivax did not differ significantly from either of the other two
groups. Urine NOx/Cr was also higher in parasitemic subjects
(median, 0.14; IQR, 0.10 to 0.23) than in aparasitemic subjects
(median, 0.07; IQR, 0.04 to 0.20; P  0.049). Urine NOx/Cr
was similar in subjects with P. falciparum and P. vivax para-
sitemia but lower in aparasitemic subjects (Fig. 3B). The dif-
ference in urine NOx/Cr between P. falciparum parasitemic
subjects and aparasitemic subjects was significant, but those
with P. vivax did not differ significantly from either of the other
two groups. There was no significant difference in NOS activity
between aparasitemic subjects and either subjects with any
malaria parasite or those with only P. falciparum or P. vivax.
There was no significant correlation between the densities of
either P. falciparum or P. vivax parasitemia and either plasma
NOx, urine NOx/Cr, or NOS activity.
Relationship between NO production and IgE. IgE levels
were elevated (normal, 100 kU/liter) in 35 of 36 Genyem
subjects for whom a result was available (median, 3,350 kU/
liter; IQR, 1,425 to 5,800). There was no significant difference
in IgE levels between parasitemic and aparasitemic subjects,
including those whose parasitemia was due only to P. falcipa-
rum, nor was IgE related to the level of parasitemia. The level
of IgE in plasma was not significantly related to either plasma
NOx, urine NOx/Cr, or NOS activity.
DISCUSSION
In contrast to what has previously been suggested (15), the
results presented here show that adults from Papua province
produce more NO than Australian adults and that P. falcipa-
rum parasitemia is associated with, and may be responsible for,
an increment in basal NO production. As found in semi-im-
mune African children (5, 49), we have shown that adults from
both urban and rural areas of Papua have marked elevation of
basal PBMC NOS activity and have near-universal basal ex-
pression of PBMC NOS2, a finding that is rare in residents of
temperate regions (71). Surprisingly, basal NOS activity in
PBMCs varied less according to the level of malaria exposure
than did the total systemic NO production. This suggests that,
in addition to inducing NOS2 in PBMCs, P. falciparum may
induce NO production from other tissue and cellular sources.
FIG. 2. Representative immunoblot showing NOS2 expression
(presence of a clear band at 131 kDa) in PBMC lysates from asymp-
tomatic residents of Genyem. Lanes: 1 and 2 (P.f. neg), absence of
P. falciparum on microscopy; 3, 4, and 5 (P.f. pos), presence of P. fal-
ciparum on microscopy; Neg, negative control (unstimulated J774
mouse macrophages); Pos, positive control (J774 cells stimulated with
lipopolysaccharide/IFN-
). Unrelated samples run in intervening lanes
have been omitted.
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The validity of these results was enhanced by strictly defining
parasitemic adults and controls as asymptomatic on the basis
of being afebrile on three occasions 24 h and having not had
symptoms suggestive of malaria in the previous week or of
other infections during enrollment. The possibility that bias
may have arisen by volunteers entering the study to seek treat-
ment for clinical malaria was minimized by additional history
taking and monitoring after enrollment that led to further
exclusion of subjects meeting these stringent criteria. Further-
more, the strict dietary controls would have minimized extra-
neous influences on NOx interpretation and the normal renal
function and similar fractional excretions of NOx ensured that
results were comparable across the three study sites. Although
urinary NOx excretion (estimated as the spot ratio of NOx to
Cr) may be a more stable measure of total systemic NO pro-
duction over time than the plasma NOx (9), both measures
were well correlated in the present study, and similar conclu-
sions can be drawn from interpretation of either data set.
The median plasma NOx of malaria-exposed adults in our
study was closer to that reported in unfasted malaria-exposed
Papua New Guinean children (median plasma NOx, 40 mol/
liter; mean age, 5 years) than Papua New Guinean adults
whose malaria exposure was unspecified (median, 12.6 mol/
liter [range, 9.5 to 34]; age range, 18 to 40 years) (15). Our
finding that systemic NOx was highest in individuals tolerant of
malaria parasitemia is consistent with the notion that NO plays
a role in the tolerance of malaria-exposed adults, as hypothe-
sized in children (6, 15), but does not prove it. Although NO
was previously thought to play a key role in mediating the
related phenomenon of endotoxin tolerance (23, 58, 77), a
growing body of evidence suggests that other mechanisms
could be more important (21). In fact, recent evidence suggests
that at least in NOS2 knockout mice, NO is dispensable for the
development of endotoxin tolerance (76). The proposed gly-
cosylphosphatidylinositol toxin of P. falciparum may instead
initiate tolerance through repeated binding to the mononu-
clear cell Toll-like receptor 2 (TLR-2) (12, 60) and induce
functionally similar events to that caused by bacterial lipopoly-
saccharide (which binds to TLR-4 [36]) (59). Induction of
cross-tolerance by ligands interacting differentially with TLR-2
and TLR-4 has been demonstrated and shown to be indepen-
dent of the activity of paracrine mediators (37), which further
suggests that NO may not be critical to this process. An alter-
native possibility (that tolerance does not result from the char-
acteristic downregulation of TNF- production seen with en-
dotoxin tolerance [72] but from resistance to the effects of
TNF-) is not supported by clinical data (1).
Whether NO is induced by malaria infection (66) and other
stimuli proportionate to the sum total of stimulation and/or via
upregulation of NOS2 induction, as occurs with endotoxin
tolerance (77), may be a moot point if the amount of NO
produced correlates with the level of tolerance. Our finding
that urban Papuan controls and aparasitemic subjects had sim-
ilar levels of PBMC activity and systemic NO production (but
that both were higher than Australian adults) may be consis-
tent with genetic differences in NO regulation or alternatively
result from stimuli present in those from Papua that were
absent from those in Darwin. It is unlikely that submicroscopic
malaria parasitemia alone accounted for these findings, since
malarial endemicity in Jayapura is low, a fact which is sup-
ported by the absence of microscopically detectable para-
sitemia from all 43 Jayapura controls. The reason for the sex-
related difference in plasma NOx (but not other measures of
NO production) in Jayapura controls is unclear. A number of
intestinal parasitic infections are endemic among individuals
living in Papua province that are rarely seen in Darwin adults
(Wayne Pederick, unpublished data). These include the hel-
minths Trichuris trichiura, Ascaris lumbricoides, Necator ameri-
FIG. 3. Relationship between parasitemia in Genyem subjects and
NO production. Shown are results from subjects with P. falciparum or
P. vivax parasitemia and from aparasitemic subjects. The results from
one subject with mixed P. falciparum and P. vivax infection are not
shown. (A) Natural logarithms of plasma NOx (in micromoles/liter).
The significance levels of pairwise comparisons are as follows: P. fal-
ciparum versus aparasitemic, P  0.022; P. vivax versus P. falciparum,
P  0.92; and P. vivax versus aparasitemic, P  0.25. (B) Natural
logarithms of urine NOx/Cr. The significance levels of pairwise com-
parisons are as follows: P. falciparum versus aparasitemic, P  0.040;
P. vivax versus P. falciparum, P  0.92; and P. vivax versus apara-
sitemic, P  0.42. In each figure, the horizontal line represents the
median and the box extends from the 25th to the 75th percentiles.
Vertical lines extend no further than the most distant datum point or
1.5 times the IQR. Outlying values are represented as small diamonds.
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canus, and Strongyloides sp., and protozoal infections such as
Entamoeba histolytica, Entamoeba coli, and Giardia lamblia (8,
19, 25, 43). It is likely that helminth infections were a major
cause of the very high levels of IgE measured in the Genyem
subjects (73) since, although P. falciparum has been linked with
elevated IgE (51), the levels are highest in cases of severe
malaria (50) and IgE was not significantly related to asymp-
tomatic P. falciparum infection in the present study.
Helminth infection has been linked to NO production in a
malaria-exposed population of Thai adults (46). This may re-
flect activation of monocyte CD23 receptors by IgE (33) or
induction of NO-inducing cytokines by helminths. IgE was not
associated with any measure of NO production in the present
study but the possibility that IgE did induce NOS2 cannot be
entirely discounted. Induction of NO production by IgE could
become saturated at a threshold IgE level that was exceeded in
most subjects or the contribution of IgE to overall NO pro-
duction may not have been detected statistically due to a type
2 error. Alternatively, IgE alone may not be sufficient to acti-
vate CD23 and the presence of IgE complexes may be more
important (45). Although helminth infections have typically
been associated with Th2 cytokine responses (16, 74), ex vivo
cytokine responses to T. trichiura and Ascaris antigens in the
whole blood of children aged 4 to 15 years from Cameroon
have been shown not to “easily fit the highly polarized Th1/Th2
paradigm,” given that production of TNF- and the potent NO
inducer gamma interferon (IFN-
) was common among older
subjects (24). This finding is in agreement with data from a
murine model showing elevated IFN-
 and NOS2 mRNA lev-
els in the spleens of A/J mice coinfected with Schistosoma
mansoni and P. chabaudi (75) but is at odds with data from
coinfected C57BL/6 mice, in which TNF- production was
reduced (28). Additionally, as part of the host defense against
amoebiasis, E. histolytica has been shown to stimulate TNF-
release leading to NO production by IFN-
-primed murine
bone marrow macrophages in vitro (64).
The increased systemic NO in subjects with all-cause malaria
parasitemia may have been unduly influenced by the larger
proportion of subjects with P. falciparum, even though the NOx
levels in subjects with non-P. falciparum parasitemia were
closer to those of subjects with P. falciparum than subjects with
other parasites. The evidence from the present study directly
linking P. falciparum parasitemia with NO production accords
with our previous finding in Tanzanian children (6) and evi-
dence from in vitro studies (66). The lack of correlation be-
tween PBMC NOS activity and systemic NO production in the
present study suggests that malaria parasitemia may induce
NO predominantly from other tissue and/or cellular sources.
This differs from the recent finding that experimental P. falci-
parum infection strongly induced PBMC NOS in malaria-naive
volunteers (53), although there may be differences in immune
responses between natural infection and those induced by ex-
perimental very-low-dose intravascular infection. Differences
in the background stimulation of PMBC NOS may also in part
account for the different relationships between parasitemia
and NOS activity observed in the present study and the one in
malaria-naive volunteers. Although the present study design
precluded assessment of the cellular origins of NO beyond
PBMCs, NOS2 expression has been demonstrated in the livers,
spleens, muscles, and colons in rodent models secondary to
induction by malaria and bacterial lipopolysaccharide (29, 32,
47, 55). Induction of NOS has also been demonstrated in
human vascular endothelial cells in response to the glyco-
sylphosphatidylinositol toxin of P. falciparum in vitro (66), and
NOS2 expression has been found in the endothelium of a
variety of tissues from patients with severe malaria (13, 39).
The magnitude of any endothelial expression in asymptomatic
infection is not known.
Genetic differences in NOS2 or related regulatory cytokine
genes could also contribute to differences in basal NO produc-
tion between Papuans and Australians given that protective
polymorphisms may undergo selection in populations with a
long history of exposure to malaria and other infections (30).
Different genetic polymorphisms have been described in the
NOS2 gene that were associated with increased (11) and re-
duced (31, 35) susceptibility to malarial disease severity, and
basal NO production was higher in Gabonese children recov-
ered from mild compared to severe malaria (49). Most re-
cently, a polymorphism in the NOS2 promoter was associated
with functional differences in NO production in asymptomatic
fasted Tanzanian children (31). The coevolution of humans
with malaria parasites and helminths and the possibility of
interspecies interactions with respect to innate immune effec-
tor mechanisms (14, 17) further increases the potential com-
plexity of this genetic selection (44). Although the present
study was not designed to answer questions relating to the role
of NO in malarial pathogenesis or resistance to the severity of
disease once it has developed, our findings provide a frame-
work within which to investigate the relationship between ge-
netic polymorphisms and basal NO production, while control-
ling for the potential confounding effects of malaria infection
and intestinal parasitosis.
In conclusion, the present study has shown that basal NO
production is higher in asymptomatic P. falciparum-parasitized
Papuan adults than in aparasitemic and urban controls, who in
turn produce more NO than urban Australian researchers not
expected to be infected with malaria or intestinal parasites
common to Papua. Although genetic polymorphisms in the
NOS2 gene or related regulatory genes may explain some of
these differences, our data are consistent with a contribution
from intestinal parasitosis, possible subclinical malaria infec-
tion, and an increment due to microscopically evident malaria
parasitemia. The contribution of PBMCs to overall NO pro-
duction was less than expected and suggests that other cellular
sources are also involved, particularly in relation to NO in-
duced by P. falciparum. These data renew the possibility that
NO could contribute to tolerance of malaria parasitemia in
adults, as may also be the case in children, which may in part
reflect an increased genetic capacity to produce NO conse-
quent upon selection by malaria and other infections such as
helminths. The complex relationships between asymptomatic
and clinical malaria, intestinal parasitosis, genetic polymor-
phisms, and NO production in populations such as these re-
quire further longitudinal study given the potential for targeted
interventions aimed at reducing the disease burden of malaria
(38, 63).
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